113 related articles for article (PubMed ID: 2546129)
1. Chronic ACTH treatment: influence on 5-HT2 receptors and behavioral supersensitivity induced by 5,7-dihydroxytryptamine lesions.
Pranzatelli MR; Eng B
Peptides; 1989; 10(1):5-8. PubMed ID: 2546129
[TBL] [Abstract][Full Text] [Related]
2. Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions.
Butler PD; Pranzatelli MR; Barkai AI
Brain Res Bull; 1990 Jan; 24(1):125-9. PubMed ID: 2155684
[TBL] [Abstract][Full Text] [Related]
3. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
4. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
Pranzatelli MR; Snodgrass SR
Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
[TBL] [Abstract][Full Text] [Related]
5. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
6. The functional significance of neonatal 5,7-dihydroxytryptamine lesions in the rat: response to selective 5-HT1A and 5-HT2,1C agonists.
Pranzatelli MR; Dollison AM; Huang YY
Brain Res Bull; 1990 Jun; 24(6):747-53. PubMed ID: 2142615
[TBL] [Abstract][Full Text] [Related]
7. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
Pranzatelli MR; Snodgrass SR
Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
[TBL] [Abstract][Full Text] [Related]
8. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
10. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
Pranzatelli MR; Snodgrass SR
Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
[TBL] [Abstract][Full Text] [Related]
11. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro effects of adrenocorticotrophic hormone on serotonin receptors in neonatal rat brain.
Pranzatelli MR
Dev Pharmacol Ther; 1989; 12(1):49-56. PubMed ID: 2470562
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
14. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
15. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
16. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
Kamei J; Ogawa M; Kasuya Y
Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
[TBL] [Abstract][Full Text] [Related]
17. p,p'-DDT myoclonic/epileptic model: serotonin receptor binding and behavioral studies in the rat.
Pranzatelli MR; Tailor PT; Pluchino R; Gonzales W; Simmens S
Neurotoxicology; 1994; 15(2):261-72. PubMed ID: 7991214
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-HT receptor subtype-selective drugs on locomotor activity and motor habituation in the DHT adult rat model.
Pranzatelli MR; Jappay E; Snodgrass SR
Pharmacol Biochem Behav; 1987 Jul; 27(3):497-504. PubMed ID: 3116560
[TBL] [Abstract][Full Text] [Related]
19. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
Pranzatelli MR; Gregory CM
Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide.
Sperk G; Stewart RM; Campbell A; Baldessarini RJ
Brain Res; 1978 Dec; 159(1):183-94. PubMed ID: 310331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
